Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

ImmuneSense Lyme Study

ClinicalTrials.gov ID: NCT04422314

Public ClinicalTrials.gov record NCT04422314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ImmuneSense Lyme is a study, which is designed to better understand the immune response to Lyme disease. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. Data collected from this study may accelerate the development of better diagnostics for Lyme disease and improve outcomes for many.

Study identification

NCT ID
NCT04422314
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Adaptive Biotechnologies
Industry
Enrollment
893 participants

Conditions and interventions

Conditions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
7 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2020 (Actual)
Primary completion
Oct 29, 2021 (Actual)
Completion
Oct 30, 2021 (Actual)
Last update posted
Apr 15, 2022

2020 – 2021

United States locations

U.S. sites
34
U.S. states
14
U.S. cities
32
Facility City State ZIP Site status
Adaptive Biotechnologies Investigational Site Danbury Connecticut 06810 —
Adaptive Biotechnologies Investigational Site Macon Georgia 31210 —
Adaptive Biotechnologies Investigational Site Savannah Georgia 31406 —
Adaptive Biotechnologies Investigational Site Baton Rouge Louisiana 70806 —
Adaptive Biotechnologies Investigational Site Lewiston Maine 04240 —
Adaptive Biotechnologies Investigational Site Elkridge Maryland 21075 —
Adaptive Biotechnologies Investigational Site Rockville Maryland 20854 —
Adaptive Biotechnologies Investigational Site Towson Maryland 21204 —
Adaptive Biotechnologies Investigational Site Beverly Massachusetts 01915 —
Adaptive Biotechnologies Investigational Site Methuen Massachusetts 01844 —
Adaptive Biotechnologies Investigational Site Springfield Massachusetts 01101 —
Adaptive Biotechnologies Investigational Site Freehold New Jersey 07728 —
Adaptive Biotechnologies Investigational Site Binghamton New York 13901 —
Adaptive Biotechnologies Investigational Site Endwell New York 13760 —
Adaptive Biotechnologies Investigational Site New Windsor New York 12553 —
Adaptive Biotechnologies Investigational Site Syracuse New York 13210 —
Adaptive Biotechnologies Investigational Site Altoona Pennsylvania 16601 —
Adaptive Biotechnologies Investigational Site Altoona Pennsylvania 16801 —
Adaptive Biotechnologies Investigational Site Hatboro Pennsylvania 19040 —
Adaptive Biotechnologies Investigational Site Pittsburgh Pennsylvania 15236 —
Adaptive Biotechnologies Investigational Site Pittsburgh Pennsylvania 15243 —
Adaptive Biotechnologies Investigational Site Scottdale Pennsylvania 15683 —
Adaptive Biotechnologies Investigational Site Smithfield Pennsylvania 15478 —
Adaptive Biotechnologies Investigational Site Tipton Pennsylvania 16684 —
Adaptive Biotechnologies Investigational Site Uniontown Pennsylvania 15401 —
Adaptive Biotechnologies Investigational Site Warwick Rhode Island 02886 —
Adaptive Biotechnologies Investigational Site Dakota Dunes South Dakota 57049 —
Adaptive Biotechnologies Investigational Site Rapid City South Dakota 57702 —
Adaptive Biotechnologies Investigational Site Burke Virginia 22015 —
Adaptive Biotechnologies Investigational Site Danville Virginia 24541 —
Adaptive Biotechnologies Investigational Site Norfolk Virginia 23502 —
Adaptive Biotechnologies Investigational Site Kingwood West Virginia 26537 —
Adaptive Biotechnologies Investigational Site Morgantown West Virginia 26501 —
Adaptive Biotechnologies Investigational Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04422314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2022 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04422314 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →